Insights into the use of biomarkers in clinical trials in Alzheimer's disease

Summary: Biomarkers have been instrumental in population selection and disease monitoring in clinical trials of recently FDA-approved drugs targeting amyloid-β to slow the progression of Alzheimer's disease (AD). As new therapeutic strategies and biomarker techniques emerge, the importance of biomar...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Tharick A. Pascoal, Cristiano S. Aguzzoli, Firoza Z. Lussier, Lucía Crivelli, Claudia K. Suemoto, Juan Fortea, Pedro Rosa-Neto, Eduardo R. Zimmer, Pamela C.L. Ferreira, Bruna Bellaver
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2024-10-01
Edice:	EBioMedicine
Témata:	Alzheimer's disease Clinical trials Biomarkers Disease-modifying therapies BEST glossary
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S235239642400358X
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!